Description of Research Expertise
I am currently a principal investigator in the Phase 1 clinical trial program at Penn, and also for ECOG-affiliated trials in the Penn GI oncology clinical research program, with my clinical focus being colorectal and anal cancers. I am/was the principal investigator for 2 trials at Penn:
1. EA2165: A Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer -- closed nationally, but data collection is still in progress; and,
2. CA020-002 (BMS): Phase 1/2a First-In-Human Study of BMS-986207 Monoclonal Antibody Alone and in Combination with Nivolumab in Advanced Solid Tumors -- in the process of closing at Penn.
I am also the Medical Monitor for Medical Monitor for UPCC trial 05519; and the Clinical Trial Medical Director for UPenn: Observational Study of a Combined Infusion System to Deliver Chemotherapy Regionally to the Liver, intended to produce a new IND for the FDA combining the Medtronics hepatic artery infusion pump with the Codman hepatic artery infusion catheter.
Academic Contact Information
10-104, Perelman Center for Advanced Medicine
3400 Civic Center Blvd
Philadelphia,
PA
19104
Phone: 215-615-5810
Patient appointments: 800-789-7366